Nanocarry
Kadima-Tzoran, IL · Founded 2021 · 12 employees on LinkedIn · 1 known investors
NanoCarry is developing a proprietary drug-delivery technology platform designed to move therapeutic antibodies across the blood-brain barrier for the treatment of brain cancers and central nervous system diseases. The platform uses a "Plug & Play" approach aimed at substantially increasing the brain delivery of injected antibody doses.
Founders & leadership
Nanocarry was founded in 2021 by Oshra Betzer.
OB
Oshra BetzerinFounder
Investors · 1
Frequently asked questions
- What does Nanocarry do?
- NanoCarry is developing a proprietary drug-delivery technology platform designed to move therapeutic antibodies across the blood-brain barrier for the treatment of brain cancers and central nervous system diseases. The platform uses a "Plug & Play" approach aimed at substantially increasing the brain delivery of injected antibody doses.
- Who founded Nanocarry?
- Nanocarry was founded by Oshra Betzer in 2021.
- Who are Nanocarry's investors?
- Nanocarry's investors include NFX.
- Where is Nanocarry headquartered?
- Nanocarry is headquartered in Kadima-Tzoran, IL.